ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,261,002 | +86.3% | 1,999,300 | +111.0% | 0.14% | +87.8% |
| Q2 2023 | $29,129,224 | +155.4% | 947,600 | +199.3% | 0.07% | +155.2% |
| Q1 2023 | $11,407,098 | -50.9% | 316,600 | -46.1% | 0.03% | -55.4% |
| Q4 2022 | $23,225,904 | -18.4% | 587,700 | -17.1% | 0.06% | -20.7% |
| Q3 2022 | $28,480,000 | -9.9% | 708,800 | -5.7% | 0.08% | -8.9% |
| Q2 2022 | $31,614,000 | +99.2% | 752,000 | +84.6% | 0.09% | +114.3% |
| Q1 2022 | $15,872,000 | +45.4% | 407,400 | +48.7% | 0.04% | +55.6% |
| Q4 2021 | $10,919,000 | +210.8% | 274,000 | +181.9% | 0.03% | +200.0% |
| Q3 2021 | $3,513,000 | – | 97,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |